Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
22,298,270
-
Share change
-
-9,773
-
Total reported value
-
$914,885,000
-
Put/Call ratio
-
162%
-
Price per share
-
$41.03
-
Number of holders
-
149
-
Value change
-
-$401,079
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2013
As of 31 Dec 2013,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,298,270 shares.
The largest 10 holders included
COMMONWEALTH BANK OF AUSTRALIA, BlackRock Group LTD, SCHRODER INVESTMENT MANAGEMENT GROUP, Fisher Asset Management, LLC, VANGUARD GROUP INC, FIL Ltd, ACADIAN ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, CREDIT SUISSE AG/, and PRUDENTIAL FINANCIAL INC.
This page lists
149
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.